Clinical trial
Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating…
NCT00070486 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00070486 |
|---|---|
| Title | Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | Randomized Phase II Study of Eicosanoid Pathway Modulators and Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, celecoxib, gemcitabine hydrochloride, zileuton |
| Enrollment | 140 |
| Start date | Dec 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | May 1, 2011 |
| First posted | Oct 7, 2003 |
| Last update posted | Jun 30, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: